Systematic renal function evaluation using iohexol or inuline clearance before lung transplantation in adult CF patients - 20/09/16

Doi : 10.1016/j.nephro.2016.07.128 
E. Novel-Catin 1, , S. Pelletier 1, R. Nove Josserand 2, Q. Reynaud 2, S. Durupt 2, L. Dubourg 3, I. Durieu 2, M. Laville 1, D. Fouque 1
1 Néphrologie-hémodialyse-nutrition rénale, centre hospitalier. Lyon-Sud, Pierre-Bénite, France 
2 Centre de ressource et de compétence mucoviscidose, centre hospitalier. Lyon-Sud, Pierre-Bénite, France 
3 Exploration fonctionnelle rénale, hospices civils de Lyon, Lyon, France 

Corresponding author.

Riassunto

Introduction

Cystic fibrosis (CF) patients are at risk for kidney injury even before undergoing lung transplantation because of prolonged exposure to aminoglycoside and complications of diabetes mellitus. The usual equations estimating the glomerular filtration rate (GFR) such as Cockroft or MDRD Formula are not adapted in CF population due to patients’ low body weight [1]. The aim of our study was to measure precisely the GFR of CF adult patients before lung transplantation.

Matériels et méthodes

Iohexol or Inuline clearance was realized in 21 adult CF patients, when they entered the lung transplant waiting list (n=17) or when the patient was considered by the clinician at high risk for renal disease (n=4). No patient was treated with aminoglycoside at the time of GFR measurement. BMI, history of diabetes mellitus and high blood pressure were recorded. Exposure to intravenous aminoglycoside within the 5 years before GFR measurement was calculated. Urines samples were collected to check for proteinuria and albuminuria.

Résultats

Our population was predominantly male (57%). Mean age at GFR measurement was 31 years old. Mean BMI was 19kg/m2. Only one patient had a history of high blood pressure, and 43% of patients were diabetic. Fourteen percent of patients had albuminuria of more than 30mg/L and none of them had proteinuria. Mean days of exposure to IV aminoglycoside therapy within the 5 years before GFR evaluation was 169 days (Ranging from 60 to 280 days). Tobramycin was the most used aminoglycoside at the mean posology of 7.6mg/kg/day. GFR was measured using iohexol for 15 patients and inuline was used for the remaining 6 patients. Mean measured GFR was 107mL/min/1.73m2. Only 2 patients had a measured GFR<90mL/min/1.73m2 for which GFR estimation using CKD EPI was unable to detect the moderate decline in kidney function (estimated GFR>90mL/min/1.73m2).

Discussion

Our sample was representative of the CF population. Despite prolonged exposition to high dose of aminoglycoside associated with a high prevalence of diabetes mellitus, no major decline in GFR is observed in our cohort.

Conclusion

There is no significant decrease in renal function in CF patients before lung transplantation.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2016  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 12 - N° 5

P. 406-407 - settembre 2016 Ritorno al numero
Articolo precedente Articolo precedente
  • Adaptation posologique et fonction rénale chez la personne âgée en officine. Résultat de l’étude IPOP
  • N. Janus, F. Cavagna, F. Beauvais, M. Garenaux, D. Livet, J.F. Bergmann, S. Pol, J. Sicard, F. Monchecourt, O. Hanon, P. Lechat, G. Deray
| Articolo seguente Articolo seguente
  • Progression de la maladie rénale diabétique en fonction de l’âge de diagnostic du diabète dans une cohorte de patients diabétiques de type 2
  • F. Alaoui, S. Alaoui, Y. Lazreg, N. Benabdellah, I. Karimi, F. Hamdi, B. Rajae, M. Lahbil, I. Haddiya, Y. Bentata

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.